LM Ruilope, E Malacco, Y Khder, A Kandra… - Clinical …, 2005 - infona.pl
AbstractRecent antihypertensive treatment guidelines recommend greater use of combination therapies. The primary objective of this study was to determine whether …
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk …
LM RUILOPE, E MALACCO, Y KHDER… - Clinical …, 2005 - pascal-francis.inist.fr
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular …
LM Ruilope, E Malacco, Y Khder, A Kandra… - Clinical …, 2005 - europepmc.org
Objectives The primary objective of this study was to determine whether combination therapy with valsartan 160 mg plus hydrochlorothiazide (HCTZ) 25 mg OD would be more …
LM Ruilope, E Malacco, Y Khder… - Clinical …, 2005 - clinicaltherapeutics.com
Background: Recent antihypertensive treatment guidelines recommend greater use of combination therapies. Objectives: The primary objective of this study was to determine …
LM Ruilope, E Malacco, Y Khder… - Clinical …, 2005 - pubmed.ncbi.nlm.nih.gov
Background Recent antihypertensive treatment guidelines recommend greater use of combination therapies. Objectives The primary objective of this study was to determine …
[引用][C]Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with …
LM Ruilope, E Malacco, Y Khder, A Kandra… - Clinical …, 2005 - Elsevier Limited